Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TTC36 and KMT2A antisense RNA 1 (TTC36-AS1)
- Target
- TTC36-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Other
01
Overview
TTC36 and KMT2A antisense RNA 1 (TTC36-AS1) is a human long non-coding RNA (lncRNA) gene located on chromosome 11q23.3 that acts as an antisense transcript to TTC36 and KMT2A. While associated with Wiedemann-Steiner Syndrome, its biological function, mechanism of action, therapeutic relevance, or drug interactions remain currently unknown and uncharacterized in available biomedical databases. It is not considered a typical therapeutic target such as a receptor, enzyme, transporter, or transcription factor[1][2][3][7][8][11]. Notes on correctness: This entry may be problematic for drug targeting or structured pharmacological classification, since TTC36-AS1 is an lncRNA with unclear function and does not match standard drug target classes. This makes it best classified as not a therapeutic target and potentially incorrect or insufficient for target-based drug discovery use[1][2][7].
- Other names
- TTC36-AS1TTC36 and KMT2A antisense RNA 1
02
Biological functions
UnknownOther
03
Disease associations
Wiedemann-Steiner Syndrome
Beyond the preview
Go deeper on TTC36 and KMT2A antisense RNA 1 (TTC36-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TTC36 and KMT2A antisense RNA 1 (TTC36-AS1).